PV pharm branch, vendor, cage 0U9U0
Ended Awarded
- Contract number
- SPE2D825F37KK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $106,489
Award facts
- Contract value 100% obligated
- $106,488.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded July 29, 2025, by the Defense Logistics Agency Medical Supply Chain to AmerisourceBergen Drug Corp, represents a firm fixed-price contract valued at $106,488.99 with an ultimate completion date of July 30, 2025. The contract is issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. This prime contract vehicle enables AmerisourceBergen to supply an extensive range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, specialty drugs, and medical devices to support military healthcare programs globally. The delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, continues to serve as a critical federal vendor for military and veteran healthcare systems through its extensive portfolio of medical product deliveries. The company's federal contract awards demonstrate its capability to fulfill diverse pharmaceutical needs across multiple therapeutic domains, including diabetes medications, neurological treatments, pain management pharmaceuticals, and antibiotics. This delivery order exemplifies the company's role within the DLA's pharmaceutical procurement strategy, which is positioning multiple prime vendors to serve separate regions under the planned Pharmaceutical Prime Vendor Global Program Generation V contracts.
Quick answers
Who was awarded contract SPE2D825F37KK?
SPE2D825F37KK was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on July 29, 2025.
How much is contract SPE2D825F37KK worth?
The government has obligated $106,489 on SPE2D825F37KK.
Is contract SPE2D825F37KK an order under another contract?
Yes. SPE2D825F37KK is a delivery order under SPE2DX22D0020, an indefinite delivery contract.
Was contract SPE2D825F37KK competed?
The extent of competition for SPE2D825F37KK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award